Edesa Biotech, Inc. (EDSA) Corporate Subsidiaries
Edesa Biotech, Inc. (EDSA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: EDSA
CIK: 1540159
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 09/30
State: A1
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
MNP LLP
Auditor SinceSince 12/31/2018 12:00:00 AM
Lead Engagement PartnerEduard Shvekher
Audit LocationToronto, Canada
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-15 | 2026-10-15 | FORM 8-K | 0001171843-26-006647 | View SEC Doc Filr Page |
| 4 | 2026-10-06 | 2026-10-05 | 4 Filing | 0001171843-26-006472 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-09-01 | 4 Filing | 0001171843-26-005844 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-26 | — | SCHEDULE 13G Filing | 0001440771-26-000020 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-25 | — | SCHEDULE 13D/A Filing | 0001171843-26-005738 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-25 | — | SCHEDULE 13D/A Filing | 0000921895-26-002310 | View SEC Doc Filr Page |
| 8-K | 2026-08-20 | 2026-08-19 | FORM 8-K | 0001171843-26-005686 | View SEC Doc Filr Page |
| 424B5 | 2026-08-20 | — | 424B5 | 0001171843-26-005685 | View SEC Doc Filr Page |
| 424B5 | 2026-08-19 | — | 424B5 | 0001171843-26-005653 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | FORM 10-Q | 0001171843-26-005502 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | FORM 8-K | 0001171843-26-005499 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-08-03 | 4 Filing | 0001171843-26-005208 | View SEC Doc Filr Page |
| EFFECT | 2026-07-13 | — | EFFECT Filing | 9999999995-26-002278 | View SEC Doc Filr Page |
| 424B3 | 2026-07-13 | — | FORM 424B3 | 0001171843-26-004604 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-07-02 | 4 Filing | 0001171843-26-004451 | View SEC Doc Filr Page |
| S-3 | 2026-07-02 | — | FORM S-3 | 0001171843-26-004449 | View SEC Doc Filr Page |
| D | 2026-06-26 | — | D Filing | 0001493152-26-030335 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-06-18 | — | SCHEDULE 13G Filing | 0001104659-26-075834 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-06-16 | — | SCHEDULE 13D/A Filing | 0001171843-26-004153 | View SEC Doc Filr Page |
| 4 | 2026-06-16 | 2026-06-16 | 4 Filing | 0001171843-26-004151 | View SEC Doc Filr Page |
| 8-K | 2026-06-11 | 2026-06-10 | FORM 8-K | 0001171843-26-004053 | View SEC Doc Filr Page |
| 8-K | 2026-06-05 | 2026-06-05 | FORM 8-K | 0001171843-26-003931 | View SEC Doc Filr Page |
| 4 | 2026-06-01 | 2026-06-01 | 4 Filing | 0001171843-26-003842 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-27 | 4 Filing | 0001171843-26-003805 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-27 | 4 Filing | 0001171843-26-003804 | View SEC Doc Filr Page |